Favorite  |  Set Home
Mirabegron (YM 178)

Mirabegron (YM 178)

Mirabegron (YM-178) is a beta-3 adrenergic agonist. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which ...
More>>
Fulvestrant (Faslodex)

Fulvestrant (Faslodex)

Fulvestrant (Faslodex) is an estrogen receptor (ER) antagonist with IC50 of 0.094 nM. Fulvestrant is efficacious in the treatment of estrogen-sensitiv...
More>>
GW 9508

GW 9508

GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32. GPR40 and GPR120 are G protein-coupled receptors (GPCR) that are activat...
More>>
Aliskiren

Aliskiren

Aliskiren is a direct renin inhibitor with an IC50 of 0.72 nM against renin. Renin is the first enzyme in the renin-angiotensin-aldosterone sys...
More>>
Raloxifene

Raloxifene

Raloxifene is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and b...
More>>
Rosuvastatin (Crestor)

Rosuvastatin (Crestor)

Rosuvastatin (Crestor) is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular ...
More>>
Fadrozole

Fadrozole

Fadrozole specifically inhibits aromatase, blocking the aromatization of androstenedione and testosterone into estrone and estradiol, respectively, th...
More>>
GW 4064

GW 4064

GW-4064 is a selective, non-steroidal farnesoid X receptor (FXR) agonist (EC50 = 15 nM).GW4064 displays no activity at other nuclear receptors at conc...
More>>
MBX 2982

MBX 2982

MBX-2982 is a potential first-in-class treatment for type 2 diabetes that targets G protein-coupled receptor 119 (GPR119), a receptor that interacts w...
More>>
Andarine (GRX 007)

Andarine (GRX 007)

Andarine (GTX 007) is an orally active partial agonist for androgen receptors. It is less potent in both anabolic and androgenic effects than other SA...
More>>
GSK1292263

GSK1292263

GSK 1292263 is a novel GPR119 receptor agonist that is currently under development for the treatment of type 2 diabetes. Treatment of male Sprague-Daw...
More>>
TAK 875

TAK 875

TAK 875 is a potent, selective and orally bioavailable GPR40 agonist with an EC50 of 0.072 μM. TAK-875 is a new agent applied in the treatment of t...
More>>
Enzalutamide (MDV3100)

Enzalutamide (MDV3100)

Enzalutamide (MDV3100) is an experimental androgen receptor antagonist drug developed by the pharmaceutical company Medivation for the treatment of ca...
More>>
Galeterone (TOK 001, VN 124)

Galeterone (TOK 001, VN 124)

Galeterone (TOK-001 or VN/124-1) is a drug that being developed by Tokai Pharmaceuticals, Inc. for the treatment of prostate cancer. It is both an and...
More>>
Total: 14 Page: 1 / 1 First ←Previous Next→ End